MEDISCA News at Your Fingertips

In compliance with a recent Drug Enforcement Administration (DEA) ruling, compounding industry leader MEDISCA has discontinued its product line containing synthetically derived CBD.

MEDISCA, a global leader in the personalized pharmaceutical industry, has announced that the revolutionary compounding technology, repurposed and optimized over a seven-year period, is available exclusively from MEDISCA, and, therefore, MEDISCA is actively taking steps to inform its competitors about MEDISCA’s expanding patent portfolio relating to its MAZ mixers.

MEDISCA names Reflex Medical as exclusive partner for SAMIX mixer repair and provides unique offer to clients.

MEDISCA Promotes Efficiency and Quality Control with New Patent for Planetary Mixers

MEDISCA celebrates its 30th anniversary as a full-service supplier for the pharmaceutical compounding industry.

MEDISCA, the industry leader in providing high quality compounding solutions and services to healthcare professionals worldwide, was granted US patent No. 10,231,903 for planetary mixers. As of March 19, 2019, MEDISCA has exclusivity around the use of melting in planetary mixing machines with additional patents pending.